Tag: Drugs and Medication
ReNetX Bio Receives Fast Track Designation From U.S. FDA
Potential First-in-Class Therapy for Chronic Spinal Cord Injury
NEW HAVEN, Conn., Jan. 08, 2020 (GLOBE NEWSWIRE) -- ReNetX Bio announced today that the U.S. Food and Drug Administration (FDA) has granted the company Fast Track Designation for...
‘Exciting’ progress for spinal injury drug
Pioneers in the field of neurological therapy want paramedics to be armed with a breakthrough drug to quickly stop the damage spreading.
It's the latest stage in the development of a project which started in...
Nutlins cancer drug may be able to reverse spinal cord damage
LONDON, UK - A group of drugs being tested for cancer treatment have been shown to present promising results for spinal cord injury in mice, according to a new report.
The cancer drug called Nutlins...
Serotonin Causes Spasms in Spinal Cord Injury Patients
Uncontrolled serotonin contributes to spasms in spinal cord injury patients, according to a study published in The Journal of Neuroscience.
Researchers from the University of Copenhagen in Denmark studied the enzyme L-amino acid decarboxylase (AADC)...
Nanoparticles Ease Inflammation In Mice With Spinal Cord Injuries
Drug Delivery: Overactive immune cells swallow Trojan horse nanoparticles that carry anti-inflammatory drugs
The human immune system can be an overenthusiastic caregiver. In a spinal cord wound, immune cells often aggravate the injury by stirring...
StemCells, Inc. Receives FDA Authorization of IND for Spinal Cord Injury
NEWARK, Calif., Oct. 2, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that the U.S. Food and Drug Administration (FDA) has authorized the Company's Investigational New Drug (IND) application for clinical testing of...
First Oral Drug for Spinal Cord Injury Improves Movement in Mice, Study Shows
COLUMBUS, Ohio – An experimental oral drug given to mice after a spinal cord injury was effective at improving limb movement after the injury, a new study shows.
The compound efficiently crossed the blood-brain barrier,...
Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline
Today Hawthorne, NY-based Acorda Therapeutics (NASDAQ: ACOR) announced that it licensed an experimental compound to treat spinal cord injury from medical-device giant Medtronic (NYSE: MDT). Acorda paid $3 million up front for worldwide rights...
Cancer Drug Improves Movement in Rats with Spine Injury
Researchers say the anti-cancer drug Taxol, normally used to treat breast cancer, might also hold promise as a way to help people recover from crippling spinal cord injuries.
Researchers at Max Planck Institute of...
Cancer Drug Aids The Regeneration Of Spinal Cord Injuries
Taxol stabilizes growing nerve cells and reduces the barrier-function of scar tissue
After a spinal cord injury a number of factors impede the regeneration of nerve cells. Two of the most important of these factors...
